Milestone Pharmaceuticals Provides 2025 Corporate Outlook and Will Host Investor Event on ...
PDUFA date of March 27, 2025 for CARDAMYST™ (etripamil) nasal spray for Paroxysmal Supraventricular Tachycardia (PSVT)- Commercial capabilities ...
Milestone Pharmaceuticals Inc.: Milestone Pharmaceuticals Provides 2025 Corporate Outlook ...
PDUFA date of March 27, 2025 for CARDAMYST (etripamil) nasal spray for Paroxysmal Supraventricular Tachycardia (PSVT) - Commercial capabilities build out in process, with proposed launch in PSVT targe ...
The EMBO Journal11 小时
Microbial metabolites tune amygdala neuronal hyperexcitability and anxiety-linked behaviors
Microbe-derived indoles modulate anxiety and neuronal excitability in the amygdala of germ-free (GF) male mice. These ...